Skip to main content
Signal8

SHEEDY CHARLES E

SEC insider (Form 3/4/5 filer). CIK 0001005483. 10% Owner at Nuo Therapeutics, Inc. (AURX). 2 reported Form 4/5 transactions since Sep 2024; latest on Jul 30, 2025. Located in HOUSTION, TX.

Companies SHEEDY CHARLES E has filed insider reports for

  • Nuo Therapeutics, Inc. (AURX): 10% Owner
SHEEDY CHARLES E profile photo

SHEEDY CHARLES E

CIK: 0001005483

Transaction Breakdown

Open Market Buys (P)2 (100.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Nuo Therapeutics, Inc. logo
AURX

Nuo Therapeutics, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Nuo Therapeutics, Inc. logo
    AURX

    Nuo Therapeutics, Inc.

    Jul 30, 2025
    Purchase
    Direct
    133.3K shares at avg. $1.50$200K
  • Nuo Therapeutics, Inc. logo
    AURX

    Nuo Therapeutics, Inc.

    Sep 18, 2024
    Purchase
    Direct
    125K shares at avg. $0.75$94K

1-2 of 2